Key result
A recently identified molecular biomarker involved in diabetes mellitus was described for its potential role in diagnosis, prognosis, and clinical management.
Why the study?
Due to the long-lasting asymptomatic manifestation of DM, discovering sensitive and specific biomarkers for diagnosis, prognosis, and clinical management is needed.
This review describes recently identified molecular biomarkers for the diagnosis and prognosis of diabetes mellitus.
Caution against premature clinical adoption in diabetes; leaves open its diagnostic and prognostic utility for validation studies.
Background: Diabetes mellitus (DM) is a growing epidemic metabolic syndrome, which affects near 5.6% of the world's population. Almost 12% of health expenditure is dedicated to this disorder. Discovering and developing biomarkers as a practical guideline with high specificity and sensitivity for the diagnosis, prognosis, and clinical management of DM is one of the subjects of great interest among DM researchers due to the long-lasting asymptomatic clinical manifestation of DM. In this study, we described a recently identified molecular biomarker involved in DM.
No takes yet. Share an insight, caveat, or question.
Zarch et al. (2020) conducted a review in Diabetes mellitus. Molecular biomarkers was evaluated. A recently identified molecular biomarker involved in diabetes mellitus was described for its potential role in diagnosis, prognosis, and clinical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: